Juliane W Schott

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Larissa Nassauer, Juliane W Schott, Jennifer Schulze, Athanasia Warnecke, Michael Morgan, Melanie Galla, Axel Schambach
The caspase-inhibitor Emricasan efficiently counteracts cisplatin- and neomycin-induced cytotoxicity in cochlear cells. Journal of molecular medicine (Berlin, Germany) 102 (9) (2024)
Larissa Nassauer, Juliane W Schott, Jennifer Schulze, Athanasia Warnecke, Michael Morgan, Melanie Galla, Axel Schambach
The caspase-inhibitor Emricasan efficiently counteracts cisplatin- and neomycin-induced cytotoxicity in cochlear cells. Journal of molecular medicine (Berlin, Germany) 102 (9) (2024)
Larissa Nassauer, Juliane W Schott, Jennifer Schulze, Athanasia Warnecke, Michael Morgan, Melanie Galla, Axel Schambach
The caspase-inhibitor Emricasan efficiently counteracts cisplatin- and neomycin-induced cytotoxicity in cochlear cells. Journal of molecular medicine (Berlin, Germany) (2024)
Larissa Nassauer, Juliane W Schott, Jennifer Schulze, Athanasia Warnecke, Michael Morgan, Melanie Galla, Axel Schambach
The caspase-inhibitor Emricasan efficiently counteracts cisplatin- and neomycin-induced cytotoxicity in cochlear cells. Journal of molecular medicine (Berlin, Germany) 102 (9) (2024)